Abstract: Embodiments of the present disclosure are directed to devices and methods for treating tricuspid valve insufficiency. For example, in some embodiments, a tricuspid insufficiency treatment device is provided, and includes a tubular member configured for implantation within a vena cava of a patient, where the tubular member is formed with a sidewall. The device also includes at least two (2) valves arranged circumferentially along the sidewall, where each valve comprises an opening formed in the sidewall, and a blocking member arranged to block and unblock a respective opening of the plurality of openings. Each blocking member comprises a flap or cover pivotally attached at or proximate a portion of a respective opening and arranged to block and unblock the opening during ventricular systole and ventricular diastole, respectively, such that the opening is unblocked in a direction opposite to the attachment of the flap or cover.
Type:
Application
Filed:
April 18, 2024
Publication date:
October 17, 2024
Applicant:
Innoventric Ltd.
Inventors:
Ori NISSAN, Amir DANINO, Yair PICHERSKY
Abstract: Embodiments of the present disclosure are directed to devices and methods for treating tricuspid valve insufficiency. For example, in some embodiments, a tricuspid insufficiency treatment device is provided, and includes a tubular member configured for implantation within a vena cava of a patient, where the tubular member is formed with a sidewall. The device also includes at least two (2) valves arranged circumferentially along the sidewall, where each valve comprises an opening formed in the sidewall, and a blocking member arranged to block and unblock a respective opening of the plurality of openings. Each blocking member comprises a flap or cover pivotally attached at or proximate a portion of a respective opening and arranged to block and unblock the opening during ventricular systole and ventricular diastole, respectively, such that the opening is unblocked in a direction opposite to the attachment of the flap or cover.
Type:
Grant
Filed:
December 8, 2020
Date of Patent:
June 4, 2024
Assignee:
INNOVENTRIC LTD.
Inventors:
Ori Nissan, Amir Danino, Yair Pichersky
Abstract: A tricuspid insufficiency treatment device includes a vena cava member (12) implantable in a vena cava of a patient. The vena cava member (12) is formed with a fenestration (14) and further includes a blocking member (16) arranged to block and unblock the fenestration (14).
Abstract: Embodiments of the present disclosure are directed to devices and methods for treating tricuspid valve insufficiency. For example, in some embodiments, a tricuspid insufficiency treatment device is provided, and includes a tubular member configured for implantation within a vena cava of a patient, where the tubular member is formed with a sidewall. The device also includes at least two (2) valves arranged circumferentially along the sidewall, where each valve comprises an opening formed in the sidewall, and a blocking member arranged to block and unblock a respective opening of the plurality of openings. Each blocking member comprises a flap or cover pivotally attached at or proximate a portion of a respective opening and arranged to block and unblock the opening during ventricular systole and ventricular diastole, respectively, such that the opening is unblocked in a direction opposite to the attachment of the flap or cover.
Type:
Application
Filed:
December 8, 2020
Publication date:
March 25, 2021
Applicant:
Innoventric Ltd.
Inventors:
Ori NISSAN, Amir DANINO, Yair PICHERSKY
Abstract: A tricuspid insufficiency treatment device includes a vena cava member (12) implantable in a vena cava of a patient. The vena cava member (12) is formed with a fenestration (14) and further includes a blocking member (16) arranged to block and unblock the fenestration (14).